Insights

Our Approach

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare

Biomeme is excited to announce that we have signed a definitive agreement to acquire Predigen, a spin-out from Duke University and global leader in the development of host gene expression signatures...

Read More

Search By Topic

Get the latest tips from Biomeme shipped right to your inbox

Our People

A First Look Inside the New Biomeme Corporate Headquarters

Biomeme’s move into its new corporate headquarters at Netrality's 401 North Broad Street, will begin an exciting new chapter for our company. Our new headquarters were announced earlier this year and...

Read More
Product Updates

Biomeme's SARS-CoV-2 Test Authorized for Emergency Use with Pooled Samples by FDA

We are pleased to announce that the U.S. Food and Drug Administration (FDA) amended Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use Authorization (EUA) for use with pooled samples in...

Read More
Product Explainers

What Type of COVID-19 Test is Right for Me?

This is a very common question, so let’s get straight to it. There are 2 kinds of tests available for COVID-19: Direct Detection - tells you if portions of the SARS-CoV-2 virus were detected in your...

Read More
Our Progress

Event Recap: U.S. Department of Homeland Security Centers of Excellence Summit 2021

With support from the Cross-Border Threat Screening and Supply Chain Defense Center of Excellence, Biomeme and Predigen were proud to recently participate in discussion and demonstration of our work...

Read More
Product Updates

Introducing SARS-CoV-2 Mutation Panel 1.0 by Biomeme

EDIT: As RNA viruses like SARS-CoV-2 continue to mutate, so will this panel. Please review our COVID-19 page for the latest information regarding our testing capabilities, including variant/mutation...

Read More
Our People

Biomeme to Open New Headquarters at Netrality’s 401 North Broad 🍾

Biomeme has officially outgrown its home at 10th and Chestnut and is moving on to Netrality’s 401 North Broad Street for its new corporate headquarters! The new headquarters boasts 44,000 square feet...

Read More
Our Progress

The Road to Reopening K-12 Schools: Biomeme To Partner with Ginkgo Bioworks

As the world crosses the 1-year mark since the World Health Organization classified COVID-19 as a pandemic, testing is still as crucial as ever. The United States tests an average of 2.78 people per...

Read More
Our Progress

Partnership Spotlight: INDICAL Bioscience

The Partnership Back in May 2019, Biomeme and INDICAL Bioscience entered into an exclusive global licensing and research agreement in a joint effort to improve animal health globally. At the time,...

Read More
Product Explainers

What to Know About SARS-CoV-2 Variants from a Leading Manufacturer of Portable PCR Testing Solutions

Table of Contents: What is a variant? Why are we just now hearing about variants of SARS-CoV-2? What are the current emerging SARS-CoV-2 variants to know? Should we be worried about these SARS-CoV-2...

Read More
Prev 2 3 4 5 6 Next